Laser ablation is a method for fabricating various kinds of nanoparticles including semiconductor quantum dots, carbon nanotubes, nanowires, and core shell nanoparticles. In this method, nanoparticles are generated by nucleation and growth of laser-vaporized species in a background gas. The extremely rapid quenching of vapor is advantageous in producing high purity nanoparticles in the quantum size range (< 10 nm). In this review, the formation mechanism of nanoparticles by laser ablation is summarized. Recent progress on the control of nanoparticle size and the challenges for functional nanoparticle synthesis by advanced laser ablation technology are then discussed.

It is known that ball milling is an energy intensive process and great efforts have been made over the years to improve energy efficiency. The use of population balance models (PBMs) can assist in the design of mineral processing circuits and the scale-up of laboratory mill results to full-scale. However, since each model has its own capabilities and limitations, it is believed that a combined use will provide more accurate information for the reliable description of the process.

In this study, the simulation of grinding of quartz is investigated in order to identify the optimal mill operating parameters. With the use of population balance modeling the specific rate of breakage and the cumulative breakage parameters can be determined from mono-size, short grinding time batch tests. The determined breakage parameters were back calculated by minimizing the residual error between experimental and reproduced size distributions. By combining two software packages the back calculated breakage parameters were used for the prediction of the optimum ball filling volume. The proposed procedure can be also applied for the identification of optimal mill operating parameters for other minerals.

In this article, applications of engineered nanoparticles containing siRNA for inhalation delivery are reviewed and discussed. Diseases with identified protein malfunctions may be mitigated through the use of well-designed siRNA therapeutics. The inhalation route of administration provides local delivery of siRNA therapeutics to the lungs for various pulmonary diseases. A siRNA delivery system can be used to overcome the barriers of pulmonary delivery, such as anatomical barriers, mucociliary clearance, cough clearance, and alveolar macrophage clearance. Apart from naked siRNA aerosol delivery, previously studied siRNA carrier systems include those of lipidic, polymeric, peptide, or inorganic origin. These delivery systems can achieve pulmonary delivery through the generation of an aerosol via an inhaler or nebulizer. The preparation methodologies for these siRNA nanocarrier systems will be discussed herein. The use of inhalable nanocarrier siRNA delivery systems have barriers to their effective delivery, but overcoming these constraints while formulating a safe and effective delivery system will offer unique advances to the field of inhaled medicine.